title: Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kinetics.
abstract: The objective of this present investigation was to develop and formulate sustained release (SR) matrix tablets of Itopride HCl, by using different polymer combinations and fillers, to optimize by Central Composite Design response surface methodology for different drug release variables and to evaluate drug release pattern of the optimized product. Sustained release matrix tablets of various combinations were prepared with cellulose-based polymers: hydroxy propyl methyl cellulose (HPMC) and polyvinyl pyrolidine (pvp) and lactose as fillers. Study of pre-compression and post-compression parameters facilitated the screening of a formulation with best characteristics that underwent here optimization study by response surface methodology (Central Composite Design). The optimized tablet was further subjected to scanning electron microscopy to reveal its release pattern. The in vitro study revealed that combining of HPMC K100M (24.65 MG) with pvp(20 mg)and use of LACTOSE as filler sustained the action more than 12 h. The developed sustained release matrix tablet of improved efficacy can perform therapeutically better than a conventional tablet.
authors: Particle Design Research Group, Universiti Teknologi MARA, 42300 Puncak Alam, Selangor, Malaysia ; Non-Destructive Biomedical and Pharmaceutical Research Centre, Universiti Teknologi MARA, 42300 Puncak Alam, Selangor, Malaysia.
authors: Anirbandeep
authors: A
authors: Bose
authors: Tin Wui
authors: TW
authors: Wong
authors: Navjot
authors: N
authors: Singh
keywords: HPMC; Itopride HCl; Release kinetics; Response surface methodology
references: Int J Pharm. 2002 Jun 20;240(1-2):103-14
references: 12062506
references: Adv Drug Deliv Rev. 2003 Sep 12;55(9):1217-31
references: 12954200
references: Drug Dev Ind Pharm. 2002 Apr;28(4):431-42
references: 12056536
references: Yakugaku Zasshi. 2007 Aug;127(8):1281-90
references: 17666882
references: J Control Release. 2001 Jun 15;73(2-3):329-38
references: 11516509
references: Pharm Res. 1993 Sep;10(9):1363-71
references: 8234178
references: J Pharm Sci. 1961 Oct;50:874-5
references: 13907269
references: J Pharm Sci. 1993 Jul;82(7):750-4
references: 8360851
references: AAPS PharmSciTech. 2003 Dec 12;4(4):E61
references: 15198556
references: Biol Pharm Bull. 2004 Oct;27(10):1626-9
references: 15467208
references: Pharm Dev Technol. 1996 Dec;1(4):381-9
references: 9552322
references: Pharm Acta Helv. 1998 Jul;73(2):105-12
references: 9700939
references: J Pharm Sci. 1963 Dec;52:1145-9
references: 14088963